Ponticelli C, Zucchelli P, Imbasciati E, Cagnoli L, Pozzi C, Grassi C, Limido D, Pasquali S, Passerini P, Volpini T, Locatelli F
Proc Eur Dial Transplant Assoc. 1983;19:717-23.
Forty-nine patients with membranous nephropathy (MN) and nephrotic syndrome (NS) were randomly allocated to supportive or specific therapy. The latter consisted of steroids or chlorambucil given in alternate months for a cumulative period of six months. Three patients in the experimental group were dropped from the study because of therapy related side-effects. At the end of follow-up there were significantly more patients in complete or partial remission in the experimental group than in the controls. The mean serum creatinine did not change in treated patients, but it significantly increased in controls.
49例膜性肾病(MN)合并肾病综合征(NS)患者被随机分配接受支持性治疗或特异性治疗。后者包括每隔一个月给予类固醇或苯丁酸氮芥,累计疗程为6个月。实验组有3名患者因治疗相关副作用退出研究。随访结束时,实验组完全或部分缓解的患者明显多于对照组。治疗患者的平均血清肌酐没有变化,但对照组显著升高。